{"source_db":"PMC","source_id":"3359311","division_id":23,"section":"Caption-Figure 5","text":"PBMCs from CF patients do not produce increased amounts of IL-1beta.\nPBMCs from CF patients (n = 17-20) and healthy controls (n = 15-19) were primed with LPS (10 ng/ml) overnight and stimulated with P. aeruginosa PAO1 (MOI = 1), P. aeruginosa PAO1 lacking exsA (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 microg/ml) for 24 hours. P. aeruginosa lacking exsA was used as a type III secretion control in comparison with wild-type P. aeruginosa. Supernatants were assayed for (A) IL-1beta and (B) IL-8.","catanns":[{"id":"T5","span":{"begin":30,"end":37},"category":"Gene_expression"},{"id":"T6","span":{"begin":38,"end":47},"category":"Positive_regulation"},{"id":"T1","span":{"begin":59,"end":67},"category":"Protein"},{"id":"T7","span":{"begin":248,"end":255},"category":"Negative_regulation"},{"id":"T2","span":{"begin":256,"end":260},"category":"Protein"},{"id":"T8","span":{"begin":341,"end":348},"category":"Negative_regulation"},{"id":"T3","span":{"begin":349,"end":353},"category":"Protein"},{"id":"T4","span":{"begin":473,"end":481},"category":"Protein"}],"insanns":[{"id":"E1","type":"instanceOf","object":"T5"},{"id":"E2","type":"instanceOf","object":"T6"},{"id":"E3","type":"instanceOf","object":"T7"},{"id":"E4","type":"instanceOf","object":"T8"}],"relanns":[{"id":"R1","type":"themeOf","subject":"T1","object":"E1"},{"id":"R2","type":"themeOf","subject":"E1","object":"E2"},{"id":"R3","type":"themeOf","subject":"T2","object":"E3"},{"id":"R4","type":"themeOf","subject":"T3","object":"E4"}],"modanns":[{"id":"M1","type":"Negation","object":"E2"}]}